NCT07075965View on ClinicalTrials.gov

Calcium Channel Blocker in Myotonic Dystrophy Type 1

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2029

Study Completion Date

October 1, 2029

Conditions
Myotonic Dystrophy 1
Interventions
DRUG

Amlodipine

Evaluating 2 different doses of amlodipine, after an initial titration phase (2.5 mg daily), amlodipine is increased to the target doses of 5 mg and 10 mg

All Listed Sponsors
lead

University of Rochester

OTHER